0078-0937 : Egaten 250 mg Oral Tablet
NDC: | 0078-0937 |
Labeler: | Novartis Pharmaceuticals Corporation |
Product Type: | Human Prescription Drug |
Drug Name: | Egaten |
Dosage Form: | Oral Tablet |
Application #: | NDA208711 |
Rev. Date: |
Appearance:
Markings: | EGEG |
Shapes: |
Capsule |
Colors: |
Red |
Size (mm): | 19 |
Segments: * | 2 |
* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 2 indicates a scored pill which can be broken into 2 equal pieces. |
NDC Package Codes:
- 0078-0937-91: 4 TABLET IN 1 BLISTER PACK (0078‑0937‑91)
Active Ingredients:
- Triclabendazole
Dosage Strength:
- 250 mg
Inactive Ingredients:
- Lactose Monohydrate
- Starch, Corn
- Hymetellose (4150 Mpa.s)
- Magnesium Stearate
- Silicon Dioxide
- Ferric Oxide Red /
Pharmaceutical Classes:
- Anthelmintic [EPC]
- Anthelmintics [CS]
- Cytochrome P450 1A2 Inhibitors [MoA]
- Cytochrome P450 2A6 Inhibitors [MoA]
- Cytochrome P450 2B6 Inhibitors [MoA]
- Cytochrome P450 2C19 Inhibitors [MoA]
- Cytochrome P450 2C8 Inhibitors [MoA]
- Cytochrome P450 2C9 Inhibitors [MoA]
- Cytochrome P450 2D6 Inhibitors [MoA]
- Cytochrome P450 3A Inhibitors [MoA]
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 0078-0930Next: 0078-0939 >
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.